Through the use of continuous-flow and other advanced manufacturing technologies, Phlow™ is dedicated to reducing costs, improving quality, sustaining our environment and moving beyond the decades old practice of traditional batch manufacturing.
For more than 50 years, pharmaceuticals have been produced using a method known as batch manufacturing — a multi-step, lengthy process that involves sizeable facilities and the use of large-scale equipment. The consumables used in production, including harmful solvents, must be procured and stored in sufficient quantities to allow for the desired maximum volume of product to be manufactured. Because of this, batch manufacturing can have a significant adverse impact on the environment, which has contributed to the offshoring of pharmaceutical production from the United States to other regions or countries with fewer environmental protection regulations and where labor costs are relatively low.
To overcome these challenges, Phlow™ leverages state-of-the-art flow technology and other advanced manufacturing processes to re-imagine the domestic production of key starting materials, active pharmaceutical ingredients (APIs) and finished pharmaceutical products critical to U.S. healthcare. Through the use of continuous-flow technology and green chemistry, Phlow™ is able to reduce costs and waste, improve quality and yield, and offer a more environmentally friendly alternative to batch manufacturing.
Why Isn’t There Enough Medicine?
This question is what led Phlow™ to become a trailblazing, public benefit company committed to ending shortages of essential medicines in our country. We started by understanding the challenges with the current essential medicines supply chain, including development, manufacturing, pricing, reimbursement and distribution. And now we are re-building critical infrastructure here at home while actively accelerating the advanced manufacturing of affordable, high-quality essential medicines at risk of shortage – including those for COVID-19 pandemic response.
Phlow™ creates active pharmaceutical ingredients (API) and finished pharmaceutical products that are essential to the Nation’s health using state-of-the-art flow technology and other advanced manufacturing processes.
With the support of a world-class team, world-class partners, and established relationships at the policy, regulatory, and federal levels Phlow™ uses continuous R&D to improve the quality and yield and reduce the cost of pharmaceutical ingredients so that one day, we can end the shortage of essential medicines – for good.
At the heart of Phlow™ is our vision, mission, and shared values.
This is the belief set that drives us in everything we do.
Vision
Make the U.S. a country where every human being has access to the essential medicines necessary to sustain life and conquer disease.
Mission
To reliably supply affordable, high-quality, essential medicines through U.S.-based advanced manufacturing processes.
Our Shared Values
Phlow’s™ shared values reflect our commitment to serving patients, as well as colleagues, partners, communities, country, and humankind. Our public benefit essential medicines company is driven by these guiding principles:
Our mission at Phlow Corp. is to reliably supply affordable, high-quality, essential medicines through U.S.-based advanced manufacturing processes. Phlow’s™ success is grounded in a culture committed to our shared values of collaboration, innovation, lifelong learning, and servant leadership. Above all, Phlow values total, unyielding integrity.
Phlow is a Public Benefit Corporation, meaning that unlike most for-profit companies, we have a legal structure that allows us to prioritize mission, values, and stakeholders as opposed to solely maximizing profit. We are currently in the process of becoming a Certified B Corporation, which is a business that meets the highest standards of verified social and environmental performance, public transparency, and legal accountability to balance profit and purpose. – Dr. Eric Edwards, Co-Founder & CEO of Phlow
We are transparent with each other, our partners, and the customers we serve. Together, we are on a journey to build a state-of-the-art pharmaceutical organization and a best place to work.